An investigation for investors in ABIOMED, Inc. (NASDAQ:ABMD) shares over potential securities laws violations by ABIOMED was announced and NASDAQ:ABMD stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 11/17/2015 -- An investigation for shareholders in ABIOMED, Inc. (NASDAQ:ABMD) shares concerning potential violations of federal securities laws in connection certain financial statements was announced.
Investors who purchased shares of ABIOMED, Inc. (NASDAQ:ABMD), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether certain statements by ABIOMED, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On October 29, 2015, ABIOMED, Inc. announced its second quarter fiscal year 2016 revenue and updated its fiscal year 2016 outlook. Shares of ABIOMED, Inc. (NASDAQ:ABMD) declined on October 29, 2015, to as low as $68.25 per share.
On November 16, 2015, NASDAQ:ABMD shares closed at $78.77 per share.
Those who purchased ABIOMED, Inc. shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com